Sex Difference in Circulating Platelet Aggregates and Response to Antiplatelet Treatment

Thromb Haemost 1982; 48(03): 341
DOI: 10.1055/s-0038-1657296

Letter to the Editor

Schattauer GmbH Stuttgart

Authors

Giuseppe G Nenci

Institutes of Semeiotica Medica, Clinica Medica and Statistica, University of Perugia Medical School, 06100 Perugia, Italy
Giancarlo Agnelli

Institutes of Semeiotica Medica, Clinica Medica and Statistica, University of Perugia Medical School, 06100 Perugia, Italy
Pasquale Parise

Institutes of Semeiotica Medica, Clinica Medica and Statistica, University of Perugia Medical School, 06100 Perugia, Italy
Francesco Merante

Institutes of Semeiotica Medica, Clinica Medica and Statistica, University of Perugia Medical School, 06100 Perugia, Italy
Enzo Ballatori

Institutes of Semeiotica Medica, Clinica Medica and Statistica, University of Perugia Medical School, 06100 Perugia, Italy

References
1 Anturan Reinfarction Italian Study. Sulphinpyrazone in post-myocardial infarction. Lancet 1982; 1: 237-242
2 Harris WH, Salzman EW, Athanasoulis CA, Waltman AC, DeSanctis RW. Aspirin prophylaxis of venous thromboembolism after total hip replacement. N Engl J Med 1977; 297: 1246-1249
3 The Canadian Cooperative Study Group. A randomized trial of aspirin and sulfinpyrazone in threatened stroke. N Engl J Med 1978; 299: 53-59
4 Kaegi A, Pineo GF, Shimizu A, Trivedi H, Hirsh J, Gent M. The role of sulfinpyrazone in the prevention of arteriovenous shunt thrombosis. Circulation 1975; 52: 497-499
5 Wu KK, Hoak JC. A new method for the quantitative detection of platelet aggregates in patients with arterial insufficiency. Lancet 1974; 2: 924-926
6 Kelton JG, Powers P, Julian J, Boland V, Carter CJ, Gent H, Hirsh J. Sex-related differences in platelet aggregation: influence of hematocrit. Blood 1980; 56: 38-41